[
    [
        {
            "time": "",
            "original_text": "“超级牛散”章建平再度出手！86天内三度举牌这家公司！这次下的什么棋？",
            "features": {
                "keywords": [
                    "超级牛散",
                    "章建平",
                    "举牌",
                    "投资动作"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "个股"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "“超级牛散”章建平再度出手！86天内三度举牌这家公司！这次下的什么棋？",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "医药生物：大品种批签发顺利上量 2019年有望见证首个百亿品种诞生",
            "features": {
                "keywords": [
                    "医药生物",
                    "大品种",
                    "批签发",
                    "百亿品种"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物：大品种批签发顺利上量 2019年有望见证首个百亿品种诞生",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 9,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2019-01",
            "original_text": "2019年1月医药行业投资策略:“轻药重医”为正道，首推医疗器械板块",
            "features": {
                "keywords": [
                    "医药行业",
                    "投资策略",
                    "轻药重医",
                    "医疗器械"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "2019年1月医药行业投资策略:“轻药重医”为正道，首推医疗器械板块",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        }
    ]
]